[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.147.69. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correspondence
February 2003

Topical Corticosteroids and Bullous Pemphigoid

Arch Dermatol. 2003;139(2):225. doi:10.1001/archderm.139.2.225-b

Systemic corticosteroids have been used extensively for 50 years in the management of inflammatory skin disorders and have become the mainstay of treatment for immunobullous disorders.1 Unfortunately, this treatment is associated with multiple potentially serious adverse effects. As a result, physicians have attempted to find efficacious corticosteroid-sparing agents to avoid the unwanted adverse effects of systemic corticosteroids. A recently published study2 demonstrated that high-potency topical corticosteroids were safer and more effective than systemic therapy in patients with bullous pemphigoid.

×